TIS 0.00% 0.0¢ tissue therapies limited

change in medical device classication?, page-3

  1. 878 Posts.
    lightbulb Created with Sketch. 2
    The review will take upto 210 calendar days. TIS as stated are ahead of the game with preparation that was made if such a case occurred.

    My read of the the the release is that we are on a goer. TIS will open up sales to many other countries as a result of EU approval.

    No doubt there will be downrampers trying to get hold of this stock but for myself as a longterm holder, the wait ahead is nowhere near the doom and gloom that I expect some to post on these threads.

    Exciting times ahead and I personally consider that TIS shares are one of the best shares I hold for future earning potential.

    We have a maximum of 210 calendar days but I anticipate that it will be shorter IMO.

    Good luck to all longterm holders.
 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.